United States| SKU-Pack Size | Availability | Size | Price | |
| EAB11771-30UL | In Stock | 30ul | $133.50 | |
| EAB11771-100UL | In Stock | 100ul | $298.50 | |
| EAB11771-200UL | In Stock | 200ul | $508.50 |
| Please select the country you are in to find your local distributor. |
| EbioCell | Phone:(540) 808-3925 | |
| Imperial Business Park 4819 Emperor Boulevard, | E-mail:order@ebiocell.com | |
| United States | Suite 408 Durham, NC 27703, USA | Web:www.ebiocell.com |
| Product Information | |
| Applications | WB |
| Species Reactivity | Human, Mouse, Rat |
| Host / Isotype | Rabbit IgG |
| Clonality | Polyclonal |
| Applications Dilutions | WB=1:500-2000 |
| MW (kDa) | 79 |
| Conjugate | Unconjugate |
| Specificity | GFAT1 Rabbit Polyclonal Antibody detects endogenous levels of GFAT1 protein. |
| Purification | Affinity purification |
| Concentration | 1mg/ml |
| Format | Liquid |
| Formulation | In PBS, pH 7.4, containing 0.02% sodium azide,0.5% BSA and 50% glycerol. |
| Shipping | Gel Pack |
| Storage | Store at -20°C least 1 year from the date of shipment. avoid repeated freeze/thaw cycles. Aliquots may be stored at +4°C for 1-2 weeks. |
| Research Use | For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. |
| Application Key WB-Western Blot IP-Immunoprecipitation IHC-Immunohistochemistry IF-Immunofluorescence ICC-Immunocytochemistry FC-Flow Cytometry |
|
| Reactivity Key H-Human M-Mouse R-Rat Mk-Monkey B-Bovine Pg-Pig Hm-Hamster Dg-Dog C-Chicken X-Xenopus Z-Zebrafish Hr-Horse All-All Species Expected |
|
| Product Bioinformatics | |
| Synonym(s) | GFA; GFAT-1; GFAT; GFAT1; GFAT1m; GFPT; Gfpt-1; GFPT1; Glutamine-fructose-6-phosphate transaminase 1 |
| Gene Aliases | GFPT1 |
| UniProt ID | |
| Entrez Gene ID | |
| Product Description | |
GFAT1 is the first and rate-limiting enzyme for the entry of glucose into the hexosamine biosynthesis pathway (HBP) in mammals. GFAT1, a member of the N-terminal nucleophile class of amidotransferases, converts fructose-6-phosphate into N-acetylglucosamine-6-phosphate. Hyperglycemia-induced insulin resistance, a condition in which exposure to high concentrations of glucose and insulin results in insulin resistance, may result from increased glucose metabolism through the HBP. Hypergylcemia-induced insulin resistance is a characteristic feature of type 2 diabetes. Consequently, GFAT1 is a potential therapeutic target in the treatment of type 2 diabetes. |
| Product Image Gallery | |
![]() Western blot analysis of extracts on 293T cells, using GFAT1 Rabbit Polyclonal Antibody (EAB11771) at 1:1000 dilution. Secondary antibody Goat Anti-Rabbit IgG (H&L)-HRP (EAB21002) at 1:5000 dilution.
|
| Specific Protocols | |